Skip to main content

MAK CAPITAL ONE LLC

Position in PLX — Protalix BioTherapeutics, Inc.

CIK 1385702 NEW YORK, NY

Position in PLX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$7,690,781
New position
Shares Held
3,544,139
first reported quarter
Ownership
4.40%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MAK CAPITAL ONE LLC holds $178,537,115 across 4 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in PLX

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-03-31 $7,690,781 3,544,139